CEO at CureVac | Transforming Healthcare Through mRNA Innovation | Bridging Science, Strategy, and Impact
Being fast on your own - or getting ahead together? In the biotech sector, there is only one answer: collaboration is the key. Without strong partnerships, innovation in our field would hardly be possible. Why? ➡️ Risk sharing Biotech development is complex and expensive. Partnerships help to share investments and risks - a decisive factor for success. ➡️ Speed A large partner not only brings financial resources, but also infrastructure, know-how and market presence. This speeds up processes enormously. ➡️ Technology transfer Large pharmaceutical companies look specifically for innovative technologies. Start-ups and specialized companies bring these to the table - a win-win situation. How do we choose the right partners? Strategically. Targeted. In the long term. But why is the whole topic so relevant? Biotech companies, especially in Europe, are often faced with the challenge of turning their research into scalable products. This is almost impossible without strong partnerships. In an environment where other countries are creating better funding conditions, strategic collaboration becomes all the more important.
Could not agree more: Collaboration is the key
I agree. Sometimes a compact team with high expertise brings more value than an entire department at large companies. Especially when start-ups and large biotech companies join forces. This is exactly what is happening in Tübingen, where scientific concentration and an innovative environment complement each other perfectly. For example, my developments in biotechnology, virology and epidemiology have found a natural continuation not only in collaboration with mathematicians and IT-AI specialists from my team, but also in cooperation with Cyber Valley, an AI accelerator that is also based in Tübingen. I am convinced that only through such interdisciplinary and inter-structural alliances can real biotechnological breakthroughs be achieved.
Thanks for sharing, Alex. Innovation and scaling up are two different sets of capabilities. Partnering with right capability partners is very important.
Thanks for sharing this Alexander! As a seasoned Strategic Alliances & Partnerships professional, I could not agree more with this post. Partnerships are absolutely essential for Biotechs, and also very important for larger Pharma companies. It is about the Win-Win-Win, with the most important Win being the Win for the eventual recipient of the drug or solution. Happy to discuss more.
Solving business problems by building software | IT Entrepreneur, CEO and Co-Founder @ CodePhusion
2moThis is exactly the problem. So many biotech startups get stuck in the valley between good research and real product. Without big partners or proper funding, they burn out before they can even prove their value